孟鲁司特（顺尔宁）对轻中度儿童哮喘患儿临床治疗效果观察.docVIP

精品论文 参考文献 孟鲁司特（顺尔宁）对轻中度儿童哮喘患儿临床治疗效果观察 尹红青 王 驰 刘海峰 刘 燕 　　四川省广汉市人民医院 四川广汉 618300 　　【摘 要】目的：探讨轻中度哮喘患儿应用孟鲁司特进行治疗的临床效果。方法：选取我院轻中度哮喘患儿作为研究对象，随机分为对照组和观察组。对照组采用常规治疗，观察组在此基础上加用孟鲁司特。观察两组患者的临床疗效，以及不良反应情况。结果：两组在不良反应发生率上相比差异不大，不具有统计学意义（P＞0.05）。但观察组治疗后症状评分低、发作次数少，PEF、FEV1、PaO2指标均优于对照组。P＜0.05，差异有统计学意义。结论：轻中度哮喘患儿应用孟鲁司特治疗具有显著的疗效，能够控制哮喘发作，改善肺功能指标，促进病情恢复，且不良反应少，值得临床推广。 　　【关键词】轻中度哮喘；孟鲁司特；临床效果；不良反应 　　【中图分类号】R256.12 【文献标识码】B 【文章编号】1764-8999（2015）7-0468-01 　　Meng LuSi te (singulair) with mild-to-moderate asthma in children with clinical effect observation 　　Yin hongqing, wang chi,liu haifeng, liu yan 　　Guanghan, sichuan province peoples hospital of pediatrics, 618300 　　【Abstract】Objective: to study the children with mild-to-moderate asthma application meng LuSi clinical effect of treatment. Methods: to choose our children with mild-to-moderate asthma as the research object, were randomly divided into control group and observation group. The control group using conventional treatment, observation group on the basis of using LuSi meng. To observe the clinical efficacy of two groups of patients, and adverse reactions. Results: two groups on the incidence of adverse reactions compared with the difference is not big, have no statistical significance (P gt; 0.05). But the observation group symptom scores after treatment is low, the fewer episodes, PEF, FEV1, PaO2 indicators are better than the control group. P lt; 0.05, the difference was statistically significant. Conclusion: children with mild-to-moderate asthma application meng LuSi has significant curative effect, can control of asthma, improve lung function index, promote disease recovery, and less adverse reactions, worthy of clinical promotion. 　　【Key words】mild-to-moderate asthma; Meng LuSi; Clinical effect; Adverse reactions 　　支气管哮喘是儿童中常见的呼吸道疾病，数据调查显示发病率呈现持续上升趋势，影响患者的正常生长和发育，甚至造成严重的不良后果[1]。为了探究孟鲁司特在该疾病的临床治疗效果，本文选取我院收治的轻中度哮喘患儿进行分析，结果如下： 　　1 资料与方法 　　1.1 一般资料 资料来源于我院收治的轻中度哮喘患儿52例，纳入时间段为2014年1月至2015年1月，将其随机分为对照组（26例）和观察组（26